Introduction

Relative to endurance athletes and the sedentary population, a greater protein need exists for strength/power athletes [13]. For strength trained individuals to maintain a positive nitrogen balance it appears that daily protein consumption should be between 1.6 to 1.8 g·kg-1·day-1 [13]. The greater protein requirement is thought to be related to the enhanced protein synthesis necessary to assist in the repair and remodeling process of skeletal muscle fibers damaged during a resistance exercise session [36]. This has important implications for improving both muscle size and strength. The beneficial effects of a high protein intake may also be reflected by improvements in body composition through increasing lean tissue accruement [7]. In addition, protein intake has been suggested to influence the anabolic hormones involved with muscle remodeling [2, 8, 9]. High protein diets and a high protein to carbohydrate ratio have been associated with altering resting concentrations of testosterone [9, 10], cortisol [11] and insulin-like growth factor concentrations [4, 12], but its effect on resting growth hormone concentrations remain inconclusive. Both increases [13] and no change [11] in resting growth hormone levels have been seen following protein consumption.

Recommendations of a greater protein requirement for resistance-trained athletes have been based on studies that have primarily examined recreationally-trained individuals and not competitive athletes. This may suggest that the protein requirements for experienced resistance trained competitive athletes may be even higher than what is presently accepted. Since protein supplementation is considered to be one of the more common nutritional supplements used by collegiate athletes [14], it is likely that many competitive athletes have daily protein intakes that exceed the recommended daily allowances. Whether daily protein intakes greater than what is presently accepted (> 1.8 g·kg-1·day-1) is efficacious for strength/power athletes is not well understood. Unfortunately many competitive athletes using nutritional supplementation often go by the 'more is better' philosophy, causing many athletes to make uneducated decisions regarding their supplementation habits [15]. Thus, to provide for a better understanding of the protein needs of these individuals the protein intakes of collegiate strength/power athletes were stratified into three separate categories of daily protein consumption; below recommended levels (1.0 – 1.4 g·kg-1·day-1), recommended levels (1.6 – 1.8 g·kg-1·day-1) and above recommended levels (> 2.0 g·kg-1·day-1). The effect of these varying daily protein intakes was examined on strength, body composition and endocrine changes during a 12-week resistance training program.

Methods

Subjects

Twenty-three male collegiate strength/power athletes volunteered for this study. Following an explanation of all procedures, risks and benefits each subject gave his informed consent to participate in this study. The Institutional Review Board of the College approved the research protocol. Subjects were not permitted to use any anabolic agents known to increase performance such as creatine, testosterone precursors, growth hormone or anabolic steroids for the six months prior to the onset of the study. Protein supplementation was considered to be acceptable for inclusion in this study to enable an increase in protein consumption. Screening for anabolic hormone use and additional supplementation was accomplished via a health questionnaire filled out during subject recruitment.

All subjects were experienced resistance trained athletes from the college's football team or sprinters or throwers from the college's track and field team with at least 2 years of resistance training experience. All subjects performed the same resistance training program for 12 weeks. The training program was a 4-day per week, split routine (see Table 1) that was supervised by research personnel. All subjects completed a daily training log and turned it in at the end of each week. In addition, all subjects completed a 3-day dietary recall every week. Based upon the average weekly protein intakes determined for the 12-week study the subjects were categorized into three groups; below recommended daily protein intake (BL; 1.0 – 1.4 g·kg-1·day-1; n = 8; 21.0 ± 1.3 y; 183.4 ± 5.1 cm; 99.7 ± 8.4 kg), recommended daily protein intake (RL; 1.6 – 1.8 g·kg-1·day-1; n = 7; 20.3 ± 1.5 y; 184.1 ± 4.0 cm; 93.3 ± 9.3 kg) and above recommended daily protein intake (AL; > 2.0 g·kg-1·day-1; n = 8; 20.7 ± 1.6 y; 179.6 ± 6.2 cm; 95.1 ± 7.5 kg).

Table 1 12-week Resistance Training Program

Dietary Recall

Dietary intake was continuously monitored throughout the study using 3-day dietary records every week. Subjects were instructed to record as accurately as possible everything they consumed during the day including between meal and late evening snacks.

Testing Protocol

Subjects reported to the Human Performance Laboratory on two separate occasions. The first testing session occurred prior to the onset of the training program (PRE) and the second testing session occurred at the conclusion of the 12-week training program (POST). All testing sessions occurred at the same time of day.

Blood Measurements

Subjects were required to arrive at the laboratory in the early morning following an overnight fast for blood draws. All blood draws occurred at the same time of day for each testing session. Each blood sample was obtained from an antecubital arm vein using a 20-gauge disposable needle equipped with a Vacutainer® tube holder (Becton Dickinson, Franklin Lakes, NJ) with the subject in a seated position. Blood samples were collected into a Vacutainer® tube containing SST® Gel and Clot Activator. Serum was allowed to clot at room temperature and subsequently centrifuged at 1500 × g for 15 minutes. The resulting serum was placed into separate 1.8-ml microcentrifuge tubes and frozen at -80°C for later analyses.

Biochemical and Hormonal Analyses

Serum total testosterone, growth hormone, IGF-I, and cortisol concentrations were determined using enzyme immunoassays (EIA) and enzyme-linked immunosorbent assays (ELISA) (Diagnostic Systems Laboratories, Webster, TX). Determinations of serum immunoreactivity values were made using a SpectraMax340 Spectrophotometer (Molecular Devices, Sunnyvale, CA). To eliminate inter-assay variance, all samples for a particular assay were thawed once and analyzed in the same assay run. All samples were run in duplicate with a mean intra-assay variance of < 10%. The molar ratio of total testosterone to cortisol (T/C ratio) was determined for each testing session.

Body Composition

Body composition was determined using whole body-dual energy x-ray absorptiometry (DEXA) scans (Prodigy™; Lunar Corporation, Madison, WI). Total body estimates of percent fat, bone mineral density and bodily content of bone, fat and non-bone lean tissue was determined using company's recommended procedures and supplied algorithms. All measures were performed by the same technician. Quality assurance was assessed by daily calibrations and was performed prior to all scans using a calibration block provided by the manufacturer.

Strength Measures

During each testing session subjects performed a one-repetition maximum (1-RM) strength test on the squat and bench press exercises. Each subject performed a warm-up set using a resistance that was approximately 40–60% of his perceived maximum, and then performed three to four subsequent attempts to determine the 1-RM. A 3 – 5 minute rest period was provided between each lift.

Statistical Analysis

Statistical evaluation of the data was accomplished by a repeated measures analysis of variance. In the event of a significant F-ratio, LSD post-hoc tests were used for pairwise comparisons. In addition, Δ comparisons between groups were analyzed with independent student's t-tests. Pearson product-moment correlation was used to examine selected bivariate correlations. A criterion alpha level of p ≤ 0.05 was used to determine statistical significance. All data are reported as mean ± SD.

Results

Average daily dietary intake is shown in Table 2. No significant difference in daily caloric intake was seen between the groups. However, significant differences in total and relative protein intake were seen between all three groups. Significant differences were also observed in carbohydrate intake between BL and AL. The protein and carbohydrate composition of the diet was also significantly different between all three groups.

Table 2 Average Daily Dietary Intake

No changes from PRE in body mass, lean body mass or percent body fat were observed in any group, and no between group differences were observed (see Table 3). Interestingly, Δ lean body mass was increased by 1.1 ± 2.2 kg in AL, 0.8 ± 1.5 kg in RL and no change (0.0 ± 1.6 kg) seen in BL. However, these changes were not significantly different.

Table 3 Anthropometric, Strength and Anaerobic Power Performance Results

Significant increases in strength from PRE were seen for all groups in the 1-RM squat and 1-RM bench press (see Table 3). However, no significant differences between the groups were seen. Although Δ strength comparisons showed that subjects in AL had the largest magnitude in strength improvements in both 1-RM squat (63% and 22% greater than BL and RL, respectively) and 1-RM bench press strength (35% and 42% greater than BL and RL, respectively), these differences were not statistically different.

Resting total testosterone, cortisol, T/C ratio, growth hormone, and IGF-I concentrations are shown in Figures 1, 2, 3, 4, 5, respectively. No significant changes from PRE were observed in any of the groups, and no between groups differences were seen in any of the hormones measured. In addition, no correlations were seen between testosterone concentrations and dietary protein intake (r = 0.09) and the protein/carbohydrate ratio (r = 0.08).

Figure 1
figure 1

Testosterone. BL = protein intake below recommended levels; RL = protein intake at recommended levels; AL = protein intake above recommended levels. All data are reported as mean ± SD.

Figure 2
figure 2

Cortisol. BL = protein intake below recommended levels; RL = protein intake at recommended levels; AL = protein intake above recommended levels. All data are reported as mean ± SD.

Figure 3
figure 3

Testosterone/cortisol ratio. BL = protein intake below recommended levels; RL = protein intake at recommended levels; AL = protein intake above recommended levels. All data are reported as mean ± SD.

Figure 4
figure 4

IGF-1. BL = protein intake below recommended levels; RL = protein intake at recommended levels; AL = protein intake above recommended levels. All data are reported as mean ± SD.

Figure 5
figure 5

Growth Hormone. BL = protein intake below recommended levels; RL = protein intake at recommended levels; AL = protein intake above recommended levels. All data are reported as mean ± SD.

Discussion

The purpose of this study was to examine whether protein intakes above recommended levels (> 2.0 g·kg-1·day-1) provided any additional benefit for strength and body composition improvements in strength/power athletes. In addition, the effect of varying protein intakes on resting hormonal concentrations was also examined. Results were unable to show any significant evidence indicating that protein intakes above 2.0 g·kg-1·day-1 were efficacious for enhancing strength and body composition changes in college strength/power athletes. In addition, elevated protein intakes in combination with resistance training were also shown not to alter resting hormonal concentrations.

However, results should be interpreted relative to energy intakes consumed by the subjects. Caloric intakes observed were low compared to levels generally recommended for strength/power athletes [1].

The low energy intakes observed in this study confirm previous reports that have shown that collegiate athletes generally do not meet their nutritional needs, specifically as it relates to energy intake [16, 17]. Caloric intakes of strength/power athletes should exceed 44 – 50 kcal·kgBM·day-1[1], however the caloric intakes reported in this study (33.0 ± 5.5 kcal·kgBM·day-1) were below these recommended levels and likely impacted the ability of these subjects to make significant gains in lean tissue accruement. Previous studies have shown that the combination of resistance training with elevated energy intake is important for stimulating significant gains in body mass and lean tissue [6, 7]. It is likely that despite protein intakes that were at or above recommended levels, the inadequate caloric consumption limited body mass and lean tissue gains.

Strength gains were seen in all three groups, however no significant differences were observed between the groups. Studies have shown that elevated protein intake is necessary for strength/power athletes to counteract the deleterious effects of muscle degradation seen following resistance exercise [4, 5, 18]. Evidence to date has only shown that protein intakes between 1.6 – 1.8 g·kg·day-1 is sufficient to maintain a positive nitrogen balance [3]. However, considering that this recommendation was based primarily on research examining recreational athletes, it was of interest to determine whether competitive resistance-trained athletes would require a higher protein intake. The thought being that experienced, competitive strength/power athletes that exercise at a high intensity and volume of training may require a greater need of protein to stimulate muscle growth and strength development. Although the results of this study do not provide statistical support for this hypothesis, a 35% and 42% greater improvement (p > 0.05) in Δ 1-RM bench press was seen by AL in comparison to BL and RL, respectively. In addition, improvements in Δ 1-RM squat were 63% and 22% greater (p > 0.05) for AL compared to BL and RL, respectively.

Results of this study also indicated that dietary protein content does not appear to influence resting hormonal concentrations. These results are similar to those reported by Bird and colleagues who showed no change in resting cortisol concentrations following several weeks of protein supplementation [19]. In addition, both growth hormone and IGF-I have also been shown to remain unchanged following protein supplementation [11]. Our results contrast with those seen by other investigators that have shown high protein intakes to elevate resting IGF-I concentrations [4, 12]. However, these studies suggested that the combination of elevated caloric consumption in addition to the high protein content contributed to the elevated resting IGF-1 response. It is likely that the relatively low energy intakes observed in the subjects of this study may have contributed to the lack of change seen in IGF-I.

No changes were observed in resting testosterone concentrations or in the T/C ratio. A limited number of studies have shown that high protein diets tend to reduce resting testosterone concentrations[10] and that both protein content and the protein-to-carbohydrate ratio are inversely related to resting testosterone concentrations [9, 10]. However, this may be a factor of high relative dietary protein consumption. The protein content of RL (21.2%) and AL (28.6%) were lower than that reported by Anderson and colleagues (44% of total energy from protein) [10], and may not influence resting testosterone concentrations to the same degree.

Conclusion

The results of this study do not provide any support for protein intakes greater than recommended levels in collegiate strength/power athletes for body composition improvements, or alterations in resting hormonal concentrations. Inadequate energy intakes likely contributed to these results. Although elevated protein content did not produce significantly greater strength improvements, results suggest that further study is warranted on the effect of high (> 2.0 g·kg-1·day-1) protein intake on strength and lean tissue accruement. However, future research needs to insure appropriate caloric consumption in the examination of strength/power athletes.